BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26616399)

  • 1. Polymeric behavior evaluation of PVP K30-poloxamer binary carrier for solid dispersed nisoldipine by experimental design.
    Kyaw Oo M; Mandal UK; Chatterjee B
    Pharm Dev Technol; 2017 Feb; 22(1):2-12. PubMed ID: 26616399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion.
    Sammour OA; Hammad MA; Megrab NA; Zidan AS
    AAPS PharmSciTech; 2006 Jun; 7(2):E55. PubMed ID: 16796372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fast disintegrating tablets of nisoldipine for intra-oral administration.
    El Maghraby GM; Elsergany RN
    Pharm Dev Technol; 2014 Sep; 19(6):641-50. PubMed ID: 23841582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.
    Srinarong P; Kouwen S; Visser MR; Hinrichs WL; Frijlink HW
    Pharm Dev Technol; 2010; 15(5):460-8. PubMed ID: 20735300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of different carriers on in vitro dissolution behavior and physicochemical characterization of glycyrrhetinic acid solid dispersions.
    Qian J; Li F; Zhang C; Chai S; Liu T; Sui X
    Pak J Pharm Sci; 2022 Nov; 35(6):1539-1548. PubMed ID: 36789813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Affecting the Dissolution of Indomethacin Solid Dispersions.
    Zhang W; Zhang CN; He Y; Duan BY; Yang GY; Ma WD; Zhang YH
    AAPS PharmSciTech; 2017 Nov; 18(8):3258-3273. PubMed ID: 28584898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on solubility enhancement of curcumin by Polyvinylpyrrolidione K30].
    Xu DH; Wang S; Mei XT; Luo XJ; Xu SB
    Zhong Yao Cai; 2008 Mar; 31(3):438-42. PubMed ID: 18619253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, optimisation, and in vitro-in vivo evaluation of febuxostat ternary solid dispersion.
    Tang J; Bao J; Shi X; Sheng X; Su W
    J Microencapsul; 2018 Aug; 35(5):454-466. PubMed ID: 30229692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization and in vitro evaluation of solid dispersions containing docetaxel.
    Chen J; Qiu L; Hu M; Jin Y; Han J
    Drug Dev Ind Pharm; 2008 Jun; 34(6):588-94. PubMed ID: 18568908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and in vitro characterization of non-effervescent floating drug delivery system of poorly soluble drug, carvedilol phosphate.
    Srikanth Meka V; Wee Liang VA; Dharmalingham SR; Sheshala R; Gorajana A
    Acta Pharm; 2014 Dec; 64(4):485-94. PubMed ID: 25531788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, characterization and tableting of cilnidipine solid dispersions.
    Hu L; Song W; Niu F; Jiao K; Jia Z
    Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution.
    Chokshi RJ; Sandhu HK; Iyer RM; Shah NH; Malick AW; Zia H
    J Pharm Sci; 2005 Nov; 94(11):2463-74. PubMed ID: 16200544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.
    Sethia S; Squillante E
    Int J Pharm; 2004 Mar; 272(1-2):1-10. PubMed ID: 15019063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Elucidation of Poloxamer 237 and Poloxamer 237/Praziquantel Solid Dispersions: Impact of Poly(Vinylpyrrolidone) over Drug Recrystallization and Dissolution.
    Orlandi S; Priotti J; Diogo HP; Leonardi D; Salomon CJ; Nunes TG
    AAPS PharmSciTech; 2018 Apr; 19(3):1274-1286. PubMed ID: 29313262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.
    Yin LF; Huang SJ; Zhu CL; Zhang SH; Zhang Q; Chen XJ; Liu QW
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1371-80. PubMed ID: 22296267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing the ability of PVP/PEG mixtures to be used as appropriate carriers for the preparation of drug solid dispersions by melt mixing technique using artificial neural networks: I.
    Papadimitriou SA; Barmpalexis P; Karavas E; Bikiaris DN
    Eur J Pharm Biopharm; 2012 Sep; 82(1):175-86. PubMed ID: 22732266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the co-grinding method to enhance the dissolution behavior of a poorly water-soluble drug: generation of solvent-free drug-polymer solid dispersions.
    Yang C; Xu X; Wang J; An Z
    Chem Pharm Bull (Tokyo); 2012; 60(7):837-45. PubMed ID: 22790815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid dispersion adsorbate technique for improved dissolution and flow properties of lurasidone hydrochloride: characterization using 3
    Mahajan A; Surti N; Koladiya P
    Drug Dev Ind Pharm; 2018 Mar; 44(3):463-471. PubMed ID: 29098883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubility enhancement of desloratadine by solid dispersion in poloxamers.
    Kolašinac N; Kachrimanis K; Homšek I; Grujić B; Ðurić Z; Ibrić S
    Int J Pharm; 2012 Oct; 436(1-2):161-70. PubMed ID: 22772487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation, characterization and and evaluation of aloe-emodin-loaded solid dispersions for dissolution enhancement.
    Xiuyan LI; Yuting L; Jinhui W; Zhimin DU
    J Tradit Chin Med; 2024 Feb; 44(1):54-62. PubMed ID: 38213239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.